NoMy and Fenja BioSolutions partner to scale mycoprotein production in Norway and the EU

Norwegian Mycelium (NoMy) and Fenja BioSolutions (Fenja) have entered into a strategic partnership to accelerate the industrialization of mycoprotein production in Norway and across Europe. The agreement brings together NoMy’s fermentation technology and Fenja’s processing expertise to develop scalable facilities that support Europe’s shift toward sustainable, locally sourced proteins.

The collaboration comes at a time when the EU and Norwegian authorities are prioritizing food security and reduced reliance on imported ingredients. NoMy’s platform uses local agricultural, aquaculture, and food industry byproducts to produce high-quality mycoprotein with a low climate footprint. Through this partnership, the two companies aim to close the gap between biotechnology, agriculture, and industry in Norway.

“We are responding to Europe’s need for increased self-sufficiency by connecting Norway’s strong, sustainable agriculture and aquaculture sectors with innovative, forward-thinking companies,” said Idar Alvestad, CEO of Fenja BioSolutions.

Fenja will be responsible for developing and delivering custom-built processing facilities to scale production. According to the companies, these systems will be designed to handle local raw materials and residual streams, advancing the use of side streams in line with circular bioeconomy principles.

“This partnership is a significant step towards industrialising protein production in Norway and Europe,” said Ingrid Dynna, CEO of NoMy. “By combining NoMy’s advanced fermentation technology with Fenja’s expertise in process industries, we are establishing a platform for sustainable value creation based on local resources. Together, we are enabling a circular bioeconomy in practice.”

The project aligns closely with initiatives promoted by Norwegian authorities, such as Råvareløftet, the Mission for Sustainable Feed, and the Blue-Green Feed Forum. It also supports the EU’s Farm to Fork Strategy and the European Green Deal, which advocate for strengthening local supply chains and reducing environmental impacts within food systems.

Fenja BioSolutions was founded by a team with deep experience in scaling commercial sustainable technologies. The company is now applying that knowledge to the mycoprotein space, aiming to bridge the gap between early-stage innovation and industrial-scale deployment.

“While much industry is moving abroad, we are building it up at home,” added Alvestad. “Together, we are creating a new industry where knowledge, resources, and technology converge.”

Oslo-based NoMy, meanwhile, has developed proprietary fermentation processes that enable value creation from otherwise underutilized residues in food and feed production. The company’s technology leverages the natural capabilities of fungi to transform these raw materials into functional ingredients, reducing waste and supporting the transition to more climate-resilient protein sources.

By focusing on local production and the use of Norwegian raw materials, the collaboration offers a model for regional protein self-sufficiency, tapping into Norway’s strengths in agriculture, aquaculture, and biotechnology.

Both companies see the partnership not only as a commercial opportunity but as a necessary response to growing pressure on global food systems.